SD Biosensor, a Korean developer of COVID-19 test kits, said Friday it has signed a deal to buy an Italian medical device distributor for 61.9 billion won ($49.8 million) in an effort to tap deeper ...
SINGAPORE - The Health Sciences Authority (HSA) said SD Biosensor and Flowflex antigen rapid test (ART) kits involved in a recall in the United States are safe and fit for use in Singapore. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results